Aethlon Medical, Inc. (AEMD) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated June 27, 2024, serves as a current report for Aethlon Medical, Inc., a Nevada corporation headquartered in San Diego, California. The filing announces the issuance of a press release detailing financial results for the fiscal year ended March 31, 2024. The company's common stock trades on The Nasdaq Capital Market under the symbol AEMD.
Key Financial Metrics
The provided text references the announcement of fiscal year results but does not contain specific numerical data. Consequently, the filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. These figures are contained within the attached press release (Exhibit 99.1), which is not included in the source text.
Material Changes
No material changes versus the prior comparable period are detailed in this specific filing text. The document functions solely as a notification that the results have been issued.
Guidance, Outlook, and Risks
The filing includes standard legal disclaimers stating that the information furnished in Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liability of that section. No specific management commentary, forward-looking guidance, or risk factors are articulated within the body of this 8-K text.
Investor Verification Checklist
- Review the attached Press Release (Exhibit 99.1) for specific revenue, net loss, and cash position figures for the fiscal year ended March 31, 2024.
- Verify the company's cash runway and burn rate based on the full financial statements referenced in the press release.
- Confirm the status of the Interim Chief Executive Officer and Chief Financial Officer, James B. Frakes, and any ongoing leadership transitions.
- Check for any subsequent filings or updates regarding the company's liquidity position following the June 27, 2024 announcement.